Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency

• Egile Nagusiak: Tianqi Wang (Egilea), Lixia Feng (Egilea), Shaomei Yang (Egilea), Yongjun Liu (Egilea), Na Zhang (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2017-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Ceramide (CE), a bioactive lipid with tumor suppression, has been widely used as a drug carrier and enhancer for cancer therapy. CE-based combination therapy was prone to be attractive in cancer therapy. In our previous study, the combination of CE and docetaxel (DTX) was proved to be an effective s...